Targeting SLC6A8 suppresses tumor growth and enhances ferroptosis in hepatocellular carcinoma
Abstract Background Hepatocellular carcinoma (HCC) persists as a therapeutic challenge owing to restricted treatment alternatives and the dearth of effective biomarkers. The creatine transporter SLC6A8 has been documented to participate in the progression of various malignancies. However, the role t...
Gardado en:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer
2026-03-01
|
| Series: | Journal of Cancer Research and Clinical Oncology |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1007/s00432-026-06442-8 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|